UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 548

Sortiert nach

Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L TRAIL-induced apoptosis

Cell death and differentiation, 2004-08, Vol.11 (8), p.915-923

2004

Link zum Volltext

Verfügbarkeit prüfen

Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis

Apoptosis (London), 2003-06, Vol.8 (3), p.237-249

2003

Link zum Volltext

Verfügbarkeit prüfen

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth

Oncogene, 2012-10, Vol.31 (43), p.4609-4618

2012

Link zum Volltext

Verfügbarkeit prüfen

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer

Oncogene, 2012-04, Vol.31 (17), p.2222-2236

2012

Link zum Volltext

Verfügbarkeit prüfen

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma

British journal of cancer, 2011-03, Vol.104 (6), p.957-967

2011

Link zum Volltext

Verfügbarkeit prüfen

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684

Journal of clinical oncology, 1996-01, Vol.14 (1), p.7-17

1996

Link zum Volltext

Verfügbarkeit prüfen

Reversal of methylation silencing of Apo2L TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L TRAIL

Oncogene, 2008-01, Vol.27 (4), p.490-498

2008

Link zum Volltext

Verfügbarkeit prüfen

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

British journal of cancer, 2006-05, Vol.94 (10), p.1465-1471

2006

Link zum Volltext

Verfügbarkeit prüfen

Biological properties of recombinant α-interferons : 40th anniversary of the discovery of interferons

Cancer research (Chicago, Ill.), 1998-06, Vol.58 (12), p.2489-2499

1998

Link zum Volltext

Verfügbarkeit prüfen

Immunoregulatory properties of ISG15, an interferon-induced cytokine

Proceedings of the National Academy of Sciences - PNAS, 1996-01, Vol.93 (1), p.211-215

1996

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine

The Journal of immunology (1950), 1996-11, Vol.157 (9), p.4100

1996

Link zum Volltext

Verfügbarkeit prüfen

Gene Modulatory Effects, Pharmacokinetics, and Clinical Tolerance of Interferon‐α1b: A Second Member of the Interferon‐α Family

Clinical pharmacology and therapeutics, 2007-03, Vol.81 (3), p.354-361

2007

Link zum Volltext

Verfügbarkeit prüfen

A perspective on the clinical effectiveness and tolerance of interferon-alpha

Seminars in oncology, 1998-02, Vol.25 (1 Suppl 1), p.3

1998

Link zum Volltext

Verfügbarkeit prüfen

Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo

Clinical cancer research, 1997-06, Vol.3 (6), p.931-937

1997

Link zum Volltext

Verfügbarkeit prüfen

Melanoma and pregnancy

Seminars in oncology, 2000-12, Vol.27 (6), p.654

Borden, E C

2000

Link zum Volltext

Verfügbarkeit prüfen

Concepts of Fever: Recent Advances and Lingering Dogma

Clinical infectious diseases, 1997-07, Vol.25 (1), p.119-138

1997

Link zum Volltext

Verfügbarkeit prüfen

Effects of tamoxifen and interferon‐β or the combination on tumor‐induced angiogenesis

International journal of cancer, 1997-05, Vol.71 (3), p.456-461

1997

Link zum Volltext

Verfügbarkeit prüfen

Identification of X-linked Inhibitor of Apoptosis-associated Factor-1 as an Interferon-stimulated Gene That Augments TRAIL Apo2L-induced Apoptosis

The Journal of biological chemistry, 2002-08, Vol.277 (32), p.28504-28511

2002

Link zum Volltext

Verfügbarkeit prüfen

A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma

The Journal of immunology (1950), 1991-10, Vol.147 (8), p.2617

1991

Link zum Volltext

Verfügbarkeit prüfen

Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-α2a) plus an anthracycline-based induction regimen

Leukemia, 2001-07, Vol.15 (7), p.1118-1122

2001

Link zum Volltext

Verfügbarkeit prüfen

An Overview of the Interferon System: Signal Transduction and Mechanisms of Action

Cancer investigation, 1996, Vol.14 (1), p.25-53

1996

Link zum Volltext

Verfügbarkeit prüfen

Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma

The New England journal of medicine, 1992-11, Vol.327 (19), p.1336-1341

1992

Link zum Volltext

Verfügbarkeit prüfen

Suppression of NF-κB Survival Signaling by Nitrosylcobalamin Sensitizes Neoplasms to the Anti-tumor Effects of Apo2L/TRAIL

The Journal of biological chemistry, 2003-10, Vol.278 (41), p.39461-39469

2003

Link zum Volltext

Verfügbarkeit prüfen

Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs

The Journal of immunology (1950), 2002-11, Vol.169 (10), p.5978-5985

2002

Link zum Volltext

Verfügbarkeit prüfen

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

Journal of clinical oncology, 2023-01, Vol.41 (3), p.425-435

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 548

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(449)
Mit Volltextzugriff
(442)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(340)
Life Sciences & Biomedicine
(303)
Humans
(284)
Biological And Medical Sciences
(157)
Female
(126)
Medical Sciences
(111)
Oncology
(106)
Animals
(100)
Male
(97)
Adult
(83)
Pharmacology. Drug Treatments
(77)
Middle Aged
(74)
Biochemistry & Molecular Biology
(61)
Aged
(58)
Antineoplastic Agents
(57)
Mice
(48)
Fundamental And Applied Biological Sciences. Psychology
(47)
Immunology
(47)
Neoplasms - Therapy
(39)
Drug Evaluation
(34)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L TRAIL-induced apoptosis

Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684

Reversal of methylation silencing of Apo2L TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L TRAIL

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

Biological properties of recombinant α-interferons : 40th anniversary of the discovery of interferons

Immunoregulatory properties of ISG15, an interferon-induced cytokine

In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine

Gene Modulatory Effects, Pharmacokinetics, and Clinical Tolerance of Interferon‐α1b: A Second Member of the Interferon‐α Family

A perspective on the clinical effectiveness and tolerance of interferon-alpha

Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo

Melanoma and pregnancy

Concepts of Fever: Recent Advances and Lingering Dogma

Effects of tamoxifen and interferon‐β or the combination on tumor‐induced angiogenesis

Identification of X-linked Inhibitor of Apoptosis-associated Factor-1 as an Interferon-stimulated Gene That Augments TRAIL Apo2L-induced Apoptosis

A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma

Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-α2a) plus an anthracycline-based induction regimen

An Overview of the Interferon System: Signal Transduction and Mechanisms of Action

Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma

Suppression of NF-κB Survival Signaling by Nitrosylcobalamin Sensitizes Neoplasms to the Anti-tumor Effects of Apo2L/TRAIL

Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

Suchergebnisse filtern